Acadia Pharmaceuticals | ACAD - EPS Earnings Per Share


Acadia Pharmaceuticals reported $1.6 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.07 0.11 May/13
FY2025Q4 Dec/2025 1.60 0.14 0.86 Feb/25
FY2025Q3 Sep/2025 0.42 0.14 0.20 Nov/05
FY2025Q2 Jun/2025 0.16 0.15 0.20 Aug/06
FY2025Q1 Mar/2025 0.11 0.01 0.10 May/07




Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
ALKERMES USD 0.29 0.2 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Cara Therapeutics USD -0.59 4.45 Sep/2025
Corcept Therapeutics USD 0.2 0.04 Dec/2025
Cytokinetics USD -1.5 1.05 Dec/2025
Eisai JPY 60.94 24.92 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Incyte USD 1.8 0.46 Dec/2025
J&J USD 2.46 0.34 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
Prothena USD -0.46 0.22 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
Vanda Pharmaceuticals USD -0.09 0 Dec/2024
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025